Latest Breaking News On - Cardioxyl pharmaceuticals - Page 1 : comparemela.com

TRIANA Biomedicines, Inc.: TRIANA Biomedicines Announces the Appointments of Vito Palombella as Chief Scientific Officer and Reza Mazhari as Chief Business Officer

TRIANA Biomedicines, Inc.: TRIANA Biomedicines Announces the Appointments of Vito Palombella as Chief Scientific Officer and Reza Mazhari as Chief Business Officer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesBaden wübergHarvard universityReza mazhariVito palombellaBrian jonesVitoj palombellaPatrick trojerBristol myers squibbJohns hopkins universityNovartis institutes for biomedical researchUniversity of california at san diegoJohns hopkins school of medicineBiomedicines incMillennium pharmaceuticalsCardioxyl pharmaceuticals

TRIANA Biomedicines Announces the Appointments of Vito Palombella as Chief Scientific Officer and Reza Mazhari as Chief Business Officer

TRIANA Biomedicines Announces the Appointments of Vito Palombella as Chief Scientific Officer and Reza Mazhari as Chief Business Officer
bostonstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bostonstar.com Daily Mail and Mail on Sunday newspapers.

United statesHarvard universityVitoj palombellaReza mazhariPatrick trojerBrian jonesVito palombellaBristol myers squibbCardioxyl pharmaceuticalsTranslational medicine at rexahn pharmaceuticalsYale universityBiomedicines incMillennium pharmaceuticalsSyntonix pharmaceuticalsUniversity of california at san diegoJohns hopkins university

Thryv Therapeutics Inc. Announces the Appointment of Dr. Debra Odink to President and Dr. Shi Yin Foo to the Board of Directors

/PRNewswire/ - Thryv Therapeutics Inc. is pleased to announce the appointment of Dr. Debra Odink to President and Chief Development Officer of the company and.

Paulf truexPeninsula pharmaceuticalsTechnical operations at anthera pharmaceuticalsThryv therapeutics incCompany researchTherapeutics incCardioxyl pharmaceuticalsDebra odinkChief development officerShi yin fooTechnical operationsSanthera pharmaceuticalsEiger biopharmaceuticalsSiteone therapeuticsThryv therapeuticsCydan therapeutics

Orna Therapeutics Bolsters Leadership Team with Key Executive and Board Appointments

/PRNewswire/ Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics.

United kingdomThomas ebelingTom barnesBristol myers squibbWilliam shenJohnson development corporationAlliance managementBayer agOncology impact fundUniversity of floridaHead of corporate developmentConsumer health divisionWharton schoolNovartis pharmaceuticalsConsumer divisionCardioxyl pharmaceuticals

Orna Therapeutics Bolsters Leadership Team with Key Executive and Board Appointments

/PRNewswire/ Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics.

United kingdomThomas ebelingTom barnesBristol myers squibbWilliam shenJohnson development corporationAlliance managementBayer agOncology impact fundUniversity of floridaHead of corporate developmentConsumer health divisionWharton schoolNovartis pharmaceuticalsConsumer divisionCardioxyl pharmaceuticals